ẢNH HƯỞNG CỦA BỘ SẢN PHẨM THỰC PHẨM CHỨC NĂNG AGELOC TR90 TRÊN HUYẾT HỌC VÀ MỘT SỐ CHỈ SỐ SINH HÓA CỦA ĐỐI TƯỢNG THỪA CÂN, BÉO PHÌ NGUYÊN PHÁT

Abstract

Objectives: To evaluate the effects of ageLOC TR90 dietary supplement set on hematology and some biochemistry of primary overweight and obese subjects. Subjects: 60 patients diagnosed with primary overweight and obesity in the community from January 2022 to December 2022. Methods: Clinical intervention study, comparing results before and after treatment. Results: After 90 days of using the product, there was a change in the following hematological and biochemical indicators: Blood count index, liver function, kidney function, blood sugar within normal limits (p > 0.05). In the group without dyslipidemia, the blood lipid index changes remained within normal limits. In the group with disorders, the cholesterol index decreased by 0.84 ± 0.70 (p < 0.05) and the LDL-C index decreased by 0.65 ± 0.50 (p < 0.05). The index of triglycerides, HDL-C changed not significantly (p > 0.05). Conclusion: The study evaluated the effects of ageLOC TR90 dietary supplement set on hematology and some biochemistry of primary overweight and obese subjects